These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
607 related articles for article (PubMed ID: 26364613)
1. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Xue X; Yang YA; Zhang A; Fong KW; Kim J; Song B; Li S; Zhao JC; Yu J Oncogene; 2016 May; 35(21):2746-55. PubMed ID: 26364613 [TBL] [Abstract][Full Text] [Related]
2. LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer. Ma T; Liang Y; Li Y; Song X; Zhang N; Li X; Chen B; Zhao W; Wang L; Yang Q Cell Signal; 2020 Apr; 68():109536. PubMed ID: 31927036 [TBL] [Abstract][Full Text] [Related]
3. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer. Peng WX; Huang JG; Yang L; Gong AH; Mo YY Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer. Lykkesfeldt AE Acta Oncol; 1996; 35 Suppl 5():9-14. PubMed ID: 9142958 [TBL] [Abstract][Full Text] [Related]
5. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. Bhan A; Hussain I; Ansari KI; Kasiri S; Bashyal A; Mandal SS J Mol Biol; 2013 Oct; 425(19):3707-22. PubMed ID: 23375982 [TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway. Wu C; Luo J Med Sci Monit; 2016 Oct; 22():3860-3867. PubMed ID: 27765938 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA Breast Cancer Res Treat; 2013 Dec; 142(3):529-36. PubMed ID: 24258260 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop. Li X; Wu Y; Liu A; Tang X Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141 [TBL] [Abstract][Full Text] [Related]
9. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance. Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers. Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705 [TBL] [Abstract][Full Text] [Related]
11. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer. Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318 [TBL] [Abstract][Full Text] [Related]
12. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells. Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368 [TBL] [Abstract][Full Text] [Related]
13. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867 [TBL] [Abstract][Full Text] [Related]
14. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer. Wang Y; Gong X; Zhang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386 [TBL] [Abstract][Full Text] [Related]
15. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression. Raha P; Thomas S; Thurn KT; Park J; Munster PN Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766 [TBL] [Abstract][Full Text] [Related]
17. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer. Girault I; Bièche I; Lidereau R Maturitas; 2006 Jul; 54(4):342-51. PubMed ID: 16822624 [TBL] [Abstract][Full Text] [Related]
18. Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. Zhou Y; Yau C; Gray JW; Chew K; Dairkee SH; Moore DH; Eppenberger U; Eppenberger-Castori S; Benz CC BMC Cancer; 2007 Apr; 7():59. PubMed ID: 17407600 [TBL] [Abstract][Full Text] [Related]
19. Fang Z; Wang Y; Wang Z; Xu M; Ren S; Yang D; Hong M; Xie W Cancer Res; 2020 Oct; 80(20):4399-4413. PubMed ID: 32826278 [TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA (lncRNA) 91H Confers Tamoxifen Resistance in ER+ Breast Cancer Cells through Inhibiting mTOR Signaling Pathway. Lv ZY; Mo QP; Tang HC; Zheng SS Ann Clin Lab Sci; 2022 Nov; 52(6):947-955. PubMed ID: 36564063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]